Kennondale Capital Management’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$753K Hold
14,108
0.77% 51
2025
Q1
$571K Sell
14,108
-14,109
-50% -$571K 0.62% 62
2024
Q4
$785K Buy
+28,217
New +$785K 0.85% 50